Cargando…

Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study

OBJECTIVE: To evaluate the risk of cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids. METHODS: Retrospective analysis of exposure to glucocorticoids in a prospective cohort of 353 patients with rheumatoid arthritis followed from June 2001 up to November 2011 for...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Sijl, Alper M., Boers, Maarten, Voskuyl, Alexandre E., Nurmohamed, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907551/ https://www.ncbi.nlm.nih.gov/pubmed/24498229 http://dx.doi.org/10.1371/journal.pone.0087965

Ejemplares similares

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis
por: Agca, Rabia, et al.
Publicado: (2021)

Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients
por: Blanken, Annelies B., et al.
Publicado: (2022)

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
por: van Boheemen, Laurette, et al.
Publicado: (2021)

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
por: Raterman, Hennie G, et al.
Publicado: (2012)

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
por: van Halm, Vokko P, et al.
Publicado: (2006)

Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care
por: Nielen, Markus MJ, et al.
Publicado: (2012)

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial
por: ter Wee, Marieke M, et al.
Publicado: (2017)

The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010)

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
por: Dijkshoorn, Bas, et al.
Publicado: (2022)

Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET
por: Verweij, Nicki, et al.
Publicado: (2022)

Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
por: Boers, Maarten
Publicado: (2023)

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?
por: Peters, Mike JL, et al.
Publicado: (2013)

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

The bounded rationality of probability distortion
por: Zhang, Hang, et al.
Publicado: (2020)

Variability in quantitative analysis of atherosclerotic plaque inflammation using (18)F-FDG PET/CT
por: Lensen, Karel-Jan D. F., et al.
Publicado: (2017)

Smartphone‐Assisted Patient‐Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial
por: Seppen, Bart, et al.
Publicado: (2022)

Atherogenic lipid profiles and its management in patients with rheumatoid arthritis
por: Nurmohamed, Michael T
Publicado: (2007)

Tracheobronchomalacia due to amyloidosis in a patient with rheumatoid arthritis
por: Turkstra, Franktien, et al.
Publicado: (2008)

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
por: Heslinga, Sjoerd C, et al.
Publicado: (2015)

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis
por: ter Wee, Marieke M., et al.
Publicado: (2016)

Productivity at work and quality of life in patients with rheumatoid arthritis
por: van Vilsteren, Myrthe, et al.
Publicado: (2015)

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
por: van Tuyl, Lilian HD, et al.
Publicado: (2014)

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
por: Choy, Ernest, et al.
Publicado: (2014)

Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
por: Kirkham, Jamie J, et al.
Publicado: (2013)

Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes: A Medical-Records Review Study
por: Seppen, Bart Fabian, et al.
Publicado: (2022)

Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis
por: Solomon, Daniel H, et al.
Publicado: (2013)

Has the rheumatoid arthritis (RA) core outcome set influenced the selection of study outcome measures?
por: Kirkham, Jamie, et al.
Publicado: (2013)

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis
por: Nurmohamed, Michael, et al.
Publicado: (2015)

Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial
por: Lucassen, M. J. J., et al.
Publicado: (2021)

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
por: den Uyl, Debby, et al.
Publicado: (2014)

Probability Distortion Depends on Choice Sequence in Rhesus Monkeys
por: Ferrari-Toniolo, Simone, et al.
Publicado: (2019)

An unfavorable body composition is common in early arthritis patients: A case control study
por: Turk, Samina A., et al.
Publicado: (2018)

Confounding factors and genetic polymorphism in the evaluation of individual steroid profiling
por: Kuuranne, Tiia, et al.
Publicado: (2014)

A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial
por: Seppen, Bart F, et al.
Publicado: (2020)

Concerning two-dimensional probability distributions of closed orbit distortions
por: Strolin, P
Publicado: (1968)

Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical Trials
por: Simon, Teresa A., et al.
Publicado: (2019)

Change of the aortic elasticity in rheumatoid arthritis: Relationship to associated cardiovascular risk factors
por: Sliem, Hamdy, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j3sipsm5lqcp8m97jbittmid3e